U.S. Drug Enforcement Administration
U.S. Government: Agencies/Departments/Divisions | Federal Agencies
Recent News About U.S. Drug Enforcement Administration
-
Biden and DEA could clash on crime, marijuana, open borders
WASHINGTON (Legal Newsline) - President Joe Biden hasn’t identified a candidate for permanent director of the Drug Enforcement Administration and it may be a long time before he does. The agency responsible for prosecuting the nation’s war on drugs is trapped on its own political battlefield as it faces criticism over its failure to contain the spread of deadly opioids while continuing to enforce a federal ban on marijuana that is opposed by White House officials and politicians on the left and right. -
DEA again cuts opioid production as companies facing addiction lawsuits put blame on feds
WASHINGTON (Legal Newsline) - The Drug Enforcement Administration has slashed oxycodone production quotas by almost 60% from the peak in 2013, including a 9% cut for this year, demonstrating the government’s firm control over narcotics distribution even as plaintiffs in opioid litigation blame pharmacies and drug distributors for causing addiction and overdose deaths by selling too many pills. -
Health care advocate: 'It is pretty clear' FDA, DEA failed to adequately protect public from opioid crisis
WASHINGTON (Legal Newsline) – The federal Food and Drug Administration and other U.S. drug enforcement arms played significant roles in causing the nation's opioid crisis and their current unwillingness to use modern technology to help combat it is "baffling," the head of a D.C.-based technology and health care advocacy group said. -
'Business decision': Did DEA boss leave opioid distributors hanging?
During the boom of the addiction crisis in America, opioid distributors were told to figure out a system for identifying suspicious orders but what they came up with could never be given a stamp of approval from federal regulators – even if they asked. -
‘Business decision’: Former DEA official works for opioid lawyers but set standards for how many pills were made
Now, Rannazzisi is helping private lawyers pin the blame squarely on manufacturers and distributors of opioids, as well as pharmacies. A post-DEA alliance with trial lawyers has been worth six figures for Rannazzisi, who has been hailed as a whistleblower by those cheering attempts to prosecute the opioid industry for the nation’s addiction crisis.